Arca Biopharma stock ($ABIO) soars on merger news

Follow Invezz on Telegram , Twitter , and Google News for instant updates >Arca Biopharma Inc (NASDAQ: ABIO) more than doubled on Wednesday after announcing a merger agreement with Oruka Therapeutics. Copy link to section The combined company following completion of the all-stock transaction will operate as Oruka Therapeutics and trade under “ORKA” on Nasdaq. Oruka – a biotech firm that focuses on novel biologics for skin diseases has already secured private financing worth $275 million to fund operations t ...